ZA757974B - Antiarrhythmia compositions and methods - Google Patents

Antiarrhythmia compositions and methods

Info

Publication number
ZA757974B
ZA757974B ZA00757974A ZA757974A ZA757974B ZA 757974 B ZA757974 B ZA 757974B ZA 00757974 A ZA00757974 A ZA 00757974A ZA 757974 A ZA757974 A ZA 757974A ZA 757974 B ZA757974 B ZA 757974B
Authority
ZA
South Africa
Prior art keywords
antiarrhythmia
compositions
methods
antiarrhythmia compositions
Prior art date
Application number
ZA00757974A
Other languages
English (en)
Inventor
Jr W Welstead
Original Assignee
Robins Co Inc A H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H filed Critical Robins Co Inc A H
Publication of ZA757974B publication Critical patent/ZA757974B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
ZA00757974A 1974-12-26 1975-12-23 Antiarrhythmia compositions and methods ZA757974B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/536,708 US4002766A (en) 1974-12-26 1974-12-26 Antiarrhythmia methods

Publications (1)

Publication Number Publication Date
ZA757974B true ZA757974B (en) 1976-12-29

Family

ID=24139598

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00757974A ZA757974B (en) 1974-12-26 1975-12-23 Antiarrhythmia compositions and methods

Country Status (18)

Country Link
US (1) US4002766A (US07655688-20100202-C00086.png)
JP (1) JPS5191255A (US07655688-20100202-C00086.png)
AU (1) AU498763B2 (US07655688-20100202-C00086.png)
BE (1) BE836974A (US07655688-20100202-C00086.png)
CA (1) CA1055396A (US07655688-20100202-C00086.png)
CH (1) CH619932A5 (US07655688-20100202-C00086.png)
DE (1) DE2558501A1 (US07655688-20100202-C00086.png)
DK (1) DK137751B (US07655688-20100202-C00086.png)
ES (1) ES443846A1 (US07655688-20100202-C00086.png)
FI (1) FI753607A (US07655688-20100202-C00086.png)
FR (1) FR2295745A1 (US07655688-20100202-C00086.png)
GB (1) GB1535770A (US07655688-20100202-C00086.png)
IE (1) IE43901B1 (US07655688-20100202-C00086.png)
NL (1) NL185620C (US07655688-20100202-C00086.png)
NO (1) NO754377L (US07655688-20100202-C00086.png)
PH (1) PH13483A (US07655688-20100202-C00086.png)
SE (1) SE428126B (US07655688-20100202-C00086.png)
ZA (1) ZA757974B (US07655688-20100202-C00086.png)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133881A (en) * 1977-04-27 1979-01-09 A. H. Robins Company, Incorporated Azetidinyl acetonitrile and acetamide antiarrhythmia compositions and methods
US4242261A (en) * 1979-07-19 1980-12-30 A. H. Robins Company, Inc. Production of methylene-cycloamines
US4260606A (en) * 1979-07-19 1981-04-07 A. H. Robins Company, Inc. 3-Methyleneazetidine derivatives
IL76583A (en) * 1984-10-19 1988-08-31 Robins Co Inc A H 1-(aminoalkyl)-alpha'alpha-diaryl pyrrolidinyl,piperidino and homopiperidino acetamides and acetonitriles and pharmaceutical compositions containing them
US4812452A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino) carbonyl and thiocarbonyl)-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4812451A (en) * 1984-10-19 1989-03-14 A. H. Robins Company, Incorporated 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha.
US4594343A (en) * 1984-10-19 1986-06-10 Shanklin Jr James R 1-[(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl]-α,α-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US4810703A (en) * 1984-10-19 1989-03-07 A. H. Robins Company, Incorporated 1-((aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-alpha, alpha-diarylpyrrolidine, piperidine and homopiperidineacetamides and acetonitriles
US5932594A (en) * 1988-11-01 1999-08-03 Pfizer, Inc. Muscarinic receptor antagonists
GB8825505D0 (en) * 1988-11-01 1988-12-07 Pfizer Ltd Therapeutic agents
US5233053A (en) * 1989-03-17 1993-08-03 Pfizer Inc. Pyrrolidine derivatives
GB8906166D0 (en) * 1989-03-17 1989-05-04 Pfizer Ltd Therapeutic agents
US6693202B1 (en) 1999-02-16 2004-02-17 Theravance, Inc. Muscarinic receptor antagonists
TW200800953A (en) * 2002-10-30 2008-01-01 Theravance Inc Intermediates for preparing substituted 4-amino-1-(pyridylmethyl) piperidine
EP1615881A2 (en) * 2003-04-01 2006-01-18 Theravance, Inc. Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
TW200510298A (en) 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
US7368463B2 (en) * 2003-07-11 2008-05-06 Theravance, Inc. Substituted 4-amino-1-benzylpiperidine compounds
JP2007528418A (ja) * 2004-03-11 2007-10-11 セラヴァンス, インコーポレーテッド ムスカリンレセプターアンタゴニストとしての有用なジフェニルメチル化合物
WO2005087722A1 (en) * 2004-03-11 2005-09-22 Theravance, Inc. Diphenylmethyl compounds useful as muscarinic receptor antagonists
TW200540154A (en) * 2004-06-10 2005-12-16 Theravance Inc Crystalline form of a substituted pyrrolidine compound
CA2626715A1 (en) * 2005-12-27 2007-07-05 Teva Pharmaceutical Industries Ltd. Processes for preparing darifenacin hydrobromide
BRPI0807615A8 (pt) * 2007-02-23 2017-12-05 Theravance Inc Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico
ES2425592T3 (es) 2007-04-24 2013-10-16 Theravance, Inc. Compuestos de amonio cuaternario de utilidad como antagonistas de los receptores muscarínicos
WO2012166909A1 (en) * 2011-06-03 2012-12-06 Galleon Pharmaceuticals, Inc. Compositions and methods for treating breathing control disorders or diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3192210A (en) * 1961-12-04 1965-06-29 Robins Co Inc A H 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-pyrrolidinones and 4-(omega-substituted alkyl)-3, 3-disubstituted-1-substituted-2-thionpyrrolidinones
US3466321A (en) * 1965-05-17 1969-09-09 Ucb Sa Derivatives of phenyl-acetic acid
US3878217A (en) * 1972-01-28 1975-04-15 Richardson Merrell Inc Alpha-aryl-4-substituted piperidinoalkanol derivatives

Also Published As

Publication number Publication date
DE2558501A1 (de) 1976-07-08
CA1055396A (en) 1979-05-29
FI753607A (US07655688-20100202-C00086.png) 1976-06-27
US4002766A (en) 1977-01-11
DK589175A (US07655688-20100202-C00086.png) 1976-06-27
BE836974A (fr) 1976-04-16
CH619932A5 (US07655688-20100202-C00086.png) 1980-10-31
NL185620B (nl) 1990-01-02
IE43901B1 (en) 1981-07-01
FR2295745A1 (fr) 1976-07-23
JPS612658B2 (US07655688-20100202-C00086.png) 1986-01-27
SE428126B (sv) 1983-06-06
IE43901L (en) 1976-06-26
DE2558501C2 (US07655688-20100202-C00086.png) 1987-07-16
PH13483A (en) 1980-05-21
NO754377L (US07655688-20100202-C00086.png) 1976-06-29
NL185620C (nl) 1990-06-01
ES443846A1 (es) 1977-07-16
FR2295745B1 (US07655688-20100202-C00086.png) 1980-06-27
DK137751B (da) 1978-05-01
AU8754975A (en) 1977-06-23
GB1535770A (en) 1978-12-13
JPS5191255A (en) 1976-08-10
NL7515071A (nl) 1976-06-29
AU498763B2 (en) 1979-03-22
DK137751C (US07655688-20100202-C00086.png) 1978-10-09
SE7514375L (sv) 1976-06-28

Similar Documents

Publication Publication Date Title
ZA757974B (en) Antiarrhythmia compositions and methods
JPS5294388A (en) Photopolymerizable composition and preparation thereof
NZ179495A (en) 1-substituted-4-benzylpiperidines and pharmaceutical compositions
AU8109175A (en) Denture means and methods
HU170012B (en) Polvinilchlorid composition
AU7711675A (en) Shampoo composition
ZA752957B (en) Insecticidal compositions and use
ZA755929B (en) Aminobenzazocines and preparation thereof
ZA754975B (en) 7-methoxy-6-thiatetracyclines and their preparation
GB1520149A (en) 4-methylthio-2-trifluoromethylmethanesulphonanilide and deivatives thereof
ZA754066B (en) Improvements in glands
PH13490A (en) Antiarrhythmia compositions and methods
IL47681A0 (en) Uv-photopolymerizable compositions
AU488782B2 (en) Improvements in reglets and associated components
PH12932A (en) Isoindole derivatives and compositions containing them
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
GB1516118A (en) 2-haloethyl-phosphonates and phosphonodithioates
JPS51118711A (en) Dividing method and compound
AU7922975A (en) Composition
JPS5170282A (en) Jizokuseino aru shigaisenkyushuseifukugofuirumu
MW5275A1 (en) Compositions
IL48133A0 (en) Agricultural compositions and methods
NZ178962A (en) 1-aryloxy-4-amino-2-butanols and pharmaceutical compositions
NZ179025A (en) Sulphonyloxy-phenyl-phosphorothiolates and-phosphorodithioates and pesticidal compositions
PH11824A (en) Benzo-naphthyridines and pharmaceutical compositions containing same